Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
64 GBX | 0.00% | 0.00% | -4.48% |
Mar. 26 | Earnings Flash (NIOX.L) NIOX GROUP Reports FY23 Revenue GBP36.8M | MT |
Mar. 26 | Earnings Flash (NIOX.L) NIOX GROUP Posts FY23 EPS GBX2.38 | MT |
Business Summary
Number of employees: 92
Sales per Business
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
NIOX
100.0
%
| 28 | 100.0 % | 31 | 100.0 % | +12.19% |
Sales per region
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Asia Pacific
34.2
%
| 11 | 38.0 % | 11 | 34.2 % | +0.94% |
European Union
30.4
%
| 8 | 29.4 % | 10 | 30.4 % | +15.85% |
United States
25.9
%
| 7 | 25.4 % | 8 | 25.9 % | +14.08% |
United Kingdom
8.9
%
| 2 | 6.1 % | 3 | 8.9 % | +64.71% |
Rest of World
0.6
%
| 0 | 1.1 % | 0 | 0.6 % | -33.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Roller
DFI | Director of Finance/CFO | 59 | 20-01-08 |
Jan Lundquist
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jonathan Emms
COO | Chief Operating Officer | - | 19-09-01 |
Investor Relations Contact | - | 20-10-31 | |
Nina Kataria
HRO | Human Resources Officer | - | 14-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Johnson
CHM | Chairman | 71 | 19-12-04 |
Michael Roller
DFI | Director of Finance/CFO | 59 | 20-01-08 |
Garry Watts
BRD | Director/Board Member | 67 | 20-03-01 |
Jonathan Emms
COO | Chief Operating Officer | - | 19-09-01 |
Director/Board Member | 60 | 18-02-07 | |
Director/Board Member | 56 | 18-02-07 | |
Director/Board Member | 34 | 20-11-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 422,746,703 | 193,940,152 ( 45.88 %) | 0 | 45.88 % |
Company contact information
Niox Group Plc
Hayakawa Building The Oxford Science Park
OX4 4GB, Oxford
+44 18 6540 5560
http://www.niox.comGroup companies
Name | Category and Sector |
---|---|
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. |
Pharmaceuticals: Other
|
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.48% | 342M | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.63% | 210B | |
+1.00% | 210B | |
-6.71% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock NIOX Group Plc - London S.E.
- Company NIOX Group Plc